About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The CORE of Innovative and Advanced Therapies at VHIR, together with the Catalan Advanced Therapies Network of BIOCAT and within the framework of the ATMP Catalonia Series, is organizing the initiative “ATMPs: From Preclinical Discovery to First-in-Human Trials”.
This conference will focus on exploring the main scientific, regulatory, ethical, and clinical challenges in the development of Advanced Therapy Medicinal Products (ATMPs), from the preclinical phase to the first clinical trials in humans. The session will bring together a diverse range of public and private partners from both academic and industry sectors to share insights and perspectives, fostering discussion on best practices and innovative approaches in the field of advanced therapies.
Program
14.15- 14.50 h Welcome and Vall d’Hebron University Campus as leaders in clinical research
14.50 - 15.10 h Kymriah and the CAR-T Revolution: Lessons from the First FDA Approval and the Road Ahead
15.10 - 15.30 h From Bench to Trial: Regulatory Requirements for ATMP Development
15.30 - 16.05 h From Preclinical to First-in-Human – Ethical, Regulatory, and Trial Design Challenges in ATMP development
16.05 - 16-20 h Coffee Break
16.20 - 16-40 h Developing Academic Therapies: An Academic Development Model
16.40 - 17-15 h Managing Uncertainty in ATMPs: High-Risk Administration, Uncertain Long-Term Durability, Immunogenicity, and Patient-Specific Biological Barriers
“To attend the event, registration is required
In-person registration: Click here
Online registration: Click here
“We look forward to seeing you there!”
